CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 21 - 30 of 842
Study Number Lead Group Study Title CIRB Study Status
MAY2016-07-01 CLO-Mayo Clinic Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Available to Open
NWU2015-06-03 CLO-Northwestern University Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer Cancer Prevention and Control CIRB Available to Open
URCC-16070 NCORP-University of Rochester Cancer Center Treatment of Refractory Nausea Cancer Prevention and Control CIRB Available to Open
A221208 Alliance Randomized Phase II Study: Corticosteroids and Bevacizumab vs. Corticosteroids and Placebo (BeSt) for Radionecrosis after Radiosurgery for Brain Metastases Cancer Prevention and Control CIRB Available to Open
S1703 SWOG Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer Cancer Prevention and Control CIRB Available to Open
A231601CD Alliance Improving Surgical Care and Outcomes In Older Cancer Patients Through Implementation of An Efficient Pre-Surgical Toolkit (OPTI-Surg) Cancer Prevention and Control CIRB Available to Open
MDA2017-09-03 CLO-MD Anderson Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing Salpingooophorectomy Cancer Prevention and Control CIRB Available to Open
WF-1802 NCORP-Wake Forest University Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW) Cancer Prevention and Control CIRB Available to Open
EAZ171 ECOG-ACRIN Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women Cancer Prevention and Control CIRB Available to Open
URCC-19085 NCORP-University of Rochester Cancer Center Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial Cancer Prevention and Control CIRB Available to Open
Displaying 21 - 30 of 842